Stock Valuation and Business Performances of Indonesia Health Care Provider Company after Post Covid 19 Pandemics (Case Study of PT. Medikaloka Hermina, Tbk.)

The Covid-19 pandemic caused a contraction in the Indonesian economy, as evidenced by large number of layoffs, and several companies had to declare bankruptcy, but this did not occur for engaged health services, including hospitals. Indonesians infected with virus hospitals experience an increase inpatient admissions, which accelerated hospitals’ financial performance very short period time. PT Mediloka Hermina, Tbk (HEAL) is private hospital greatest branches Indonesia, all are impacted pandemic. This also positive sentiment among stock investors, they perceive industry sector have promising future prospects. Several listed company on IDX seen their share prices significantly over past year, PT. Tbk, whose price increased 197 percent between 23 March 2020 2021. made author curious about Tbk’s valuation whether its shares classified overvalued or undervalued. study utilizes secondary data obtained from annual report well idx.co.id stockbit.com, others. was processed absolute method (Discounted Cash Flow) relative (Relative Value) mind (EV EBITDA Price Earnings Ratio). Using Discounted Flow model, company’s intrinsic value IDR 452.80 per share. It has safety margin -135 per-share market 1,065 31 December 688 based price-to-earnings ratio EV 7.21. Following evaluation procedure. may determine relationship HEAL’s fundamental growth.